RTI Surgical Inc. (NASDAQ:RTIX) shares saw an uptick in trading volume on Thursday . 340,194 shares changed hands during mid-day trading, an increase of 103% from the previous session’s volume of 167,368 shares.The stock last traded at $3.32 and had previously closed at $3.43.

Several brokerages have issued reports on RTIX. Zacks Investment Research upgraded shares of RTI Surgical from a “hold” rating to a “strong-buy” rating and set a $4.75 price target on the stock in a research note on Wednesday, April 20th. Craig Hallum lowered shares of RTI Surgical from a “buy” rating to a “hold” rating in a research note on Thursday.

The stock has a market capitalization of $186.59 million and a P/E ratio of 18.25. The company’s 50-day moving average price is $3.72 and its 200 day moving average price is $3.71.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Wednesday, July 27th. The company reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of $0.03 by $0.08. The firm had revenue of $67.60 million for the quarter, compared to the consensus estimate of $66.52 million. The business’s revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.04 earnings per share. On average, analysts expect that RTI Surgical Inc. will post $0.17 earnings per share for the current year.

A number of hedge funds and institutional investors recently modified their holdings of RTIX. Royce & Associates LLC raised its position in shares of RTI Surgical by 30.9% in the fourth quarter. Royce & Associates LLC now owns 1,558,774 shares of the company’s stock valued at $6,188,000 after buying an additional 368,000 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of RTI Surgical by 1.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,595,287 shares of the company’s stock valued at $14,273,000 after buying an additional 44,725 shares in the last quarter. Finally, Paradigm Capital Management Inc. NY raised its position in shares of RTI Surgical by 17.4% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 4,438,200 shares of the company’s stock valued at $17,620,000 after buying an additional 658,474 shares in the last quarter.

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.